% | $
Quotes you view appear here for quick access.

Opko Health, Inc. Message Board

holycowitsterrific 6 posts  |  Last Activity: Nov 12, 2015 10:32 AM Member since: Aug 15, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Pssst.... Inside scoop

    by edfiggy Nov 11, 2015 1:43 PM
    holycowitsterrific holycowitsterrific Nov 12, 2015 10:32 AM Flag

    who knows Ed, maybe we will get a card on the conference call that say's, "move to go and collect $200.00 and a stay out of jail card." Who knows, only the nose knows for sure - GLTU

  • holycowitsterrific by holycowitsterrific Oct 19, 2015 9:54 AM Flag

    Guided Therapeutics’ Fourth Quarter Orders of LuViva® Advanced Cervical Scan Disposables Triple 2014 Total Sales
    Oct 19, 2015

    OTC Disclosure & News Service


    Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it expects to ship 25 LuViva® Advance Cervical Scan units and approximately 40,000 single-patient-use disposables in the fourth quarter of 2015.

    The shipments are destined for Turkey, Saudi Arabia and Indonesia with manufacturing underway at the Guided Therapeutics facility in Norcross, Georgia.

    For the year, the company expects to have shipped 45 LuViva units and approximately 45,000 disposables generating revenue of $1.1 million. This compares to 41 units and approximately 15,000 disposables in 2014 for revenue of $758,000.

    “The tremendous burst of sales in the fourth quarter is reflective of closing the Turkish Ministry of Health order and shows the opportunity for growth based on our strategy of working with governments,” said Gene Cartwright, CEO of Guided Therapeutics. “Our primary targets are countries that need a point-of-care solution for cervical cancer screening of large underserved populations.”

    Worldwide, the market for cervical cancer screening and diagnostics, as currently practiced using cytology (Pap test) for primary screening, is estimated at $6 billion and is projected to grow to almost $9 billion by 2020. There are about 2.6 billion women aged 15 years and older who are at risk of developing cervical cancer worldwide.

    About LuViva® Advanced Cervical Scan

    LuViva is a technologically advanced diagnostic device that scans the cervix with light and uses spectroscopy to measure how light interacts with the cervical tissue. Spectroscopy identifies chemical and structural indicators of precancer that may be below the surface of the cervix or misdiagnosed as benign. This technique is called biophotonics. Unlike Pap, HPV tests or biop

  • Reply to

    It's time!!

    by baci7470 Oct 1, 2015 8:23 AM
    holycowitsterrific holycowitsterrific Oct 7, 2015 11:16 AM Flag

    Of course that's correct ingtrmspcultor, EU not the FDA, sheezz, my bad - gltu

  • Reply to

    It's time!!

    by baci7470 Oct 1, 2015 8:23 AM
    holycowitsterrific holycowitsterrific Oct 2, 2015 11:44 AM Flag

    Agree baci, but not sure when trial commencement will start. They are obviously waiting for the FDA to give the go ahead so it might take a bit, maybe November. But, when it is announced and your right, it could be any day, the PPS will start to move up slowly like it did in the 3rd week of August until they said they are waiting for regulators to say the word and that is where we are now, waiting & waiting and so on - GLTU

  • Reply to

    A birthday wish...

    by lwe6638 Sep 14, 2015 9:55 AM
    holycowitsterrific holycowitsterrific Sep 14, 2015 1:32 PM Flag

    Happy Happy LWE, I too am having a birthday this month & I am a bit older turning, .......... Yep, I too wish upon a star for GTHP - GLTU


  • Reply to


    by kar26dav Sep 7, 2015 6:42 AM
    holycowitsterrific holycowitsterrific Sep 8, 2015 3:22 PM Flag

    Mr Kar, hope you are doing well also. I see you might be invested here in ONCS but are you also in ARTH? Best always

10.98-0.11(-0.99%)Nov 27 1:00 PMEST